Free Trial

IperionX Limited Sponsored ADR (NASDAQ:IPX) Short Interest Down 29.8% in July

IperionX logo with Industrials background

Key Points

  • The short interest for IperionX Limited (NASDAQ:IPX) decreased by 29.8% in July, falling to 128,200 shares from 182,700 shares.
  • Shares of IperionX traded down 6.5% to $38.38 amid a trading volume of 75,525 shares.
  • Several institutional investors have recently increased their stakes in IperionX, with Stifel Financial Corp boosting its ownership by 27.9% in the fourth quarter.
  • Looking to export and analyze IperionX data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report) was the target of a significant decline in short interest in July. As of July 31st, there was short interest totaling 128,200 shares, adeclineof29.8% from the July 15th total of 182,700 shares. Based on an average daily trading volume, of 63,800 shares, the days-to-cover ratio is currently 2.0 days. Currently,0.4% of the shares of the stock are sold short. Currently,0.4% of the shares of the stock are sold short. Based on an average daily trading volume, of 63,800 shares, the days-to-cover ratio is currently 2.0 days.

Institutional Trading of IperionX

Several hedge funds and other institutional investors have recently bought and sold shares of IPX. Marshall Wace LLP purchased a new stake in IperionX in the fourth quarter worth approximately $465,000. Stifel Financial Corp boosted its stake in IperionX by 27.9% in the fourth quarter. Stifel Financial Corp now owns 900,237 shares of the company's stock worth $30,968,000 after buying an additional 196,558 shares in the last quarter. Mercer Global Advisors Inc. ADV purchased a new stake in IperionX in the fourth quarter worth approximately $602,000. Bank of America Corp DE boosted its stake in IperionX by 15.8% in the fourth quarter. Bank of America Corp DE now owns 24,193 shares of the company's stock worth $832,000 after buying an additional 3,293 shares in the last quarter. Finally, Citadel Advisors LLC purchased a new stake in IperionX in the fourth quarter worth approximately $283,000. Hedge funds and other institutional investors own 2.76% of the company's stock.

IperionX Stock Down 6.5%

Shares of IPX stock traded down $2.67 during trading on Wednesday, hitting $38.38. The company had a trading volume of 75,525 shares, compared to its average volume of 69,768. The stock's 50-day moving average is $33.87 and its two-hundred day moving average is $26.01. IperionX has a 52 week low of $12.27 and a 52 week high of $42.38.

Analyst Upgrades and Downgrades

IPX has been the subject of a number of research analyst reports. B. Riley dropped their price target on IperionX from $30.00 to $28.00 and set a "buy" rating for the company in a research report on Tuesday, April 22nd. Roth Capital began coverage on shares of IperionX in a research report on Wednesday. They issued a "buy" rating and a $64.00 price objective on the stock. Finally, Wall Street Zen upgraded shares of IperionX from a "sell" rating to a "hold" rating in a research report on Friday, June 6th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $46.00.

Get Our Latest Stock Report on IPX

About IperionX

(Get Free Report)

IperionX's mission is to be the leading developer of low carbon, sustainable, critical material supply chains focused on advanced industries including space, aerospace, electric vehicles and 3D printing. IperionX's breakthrough titanium technologies have demonstrated the potential to produce titanium products that are sustainable, 100% recyclable, have low carbon intensity and to do so at product qualities that meet or exceed current industry standards.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in IperionX Right Now?

Before you consider IperionX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IperionX wasn't on the list.

While IperionX currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines